Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119764) titled 'A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients with Recurrent Glioblastoma (rGBM)' on March 3.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Huashan Hospital, Shanghai Medical College, Fudan University;
Beijing TianTan Hospital,Capital Medical University
Condition:
recurrent glioblastoma (rGBM)
Intervention:
Dose Group 1:Intratumoral or intracavitary administration of JL15003 Injection
Dose Group 2:Intratumoral or intracavitary administration of JL15003 Injection
Recruitment Status: Not Recruiting
Phase: 1-2
...